期刊文献+

老年抑郁症应用度洛西汀与帕罗西汀治疗的效果对照评析 被引量:1

Application of Duloxetine Depression Treated with Paroxetine Effect Evaluation
下载PDF
导出
摘要 目的对比老年抑郁症应用度洛西汀与帕罗西汀治疗的临床疗效。方法将我院118例老年抑郁症患者依据治疗方式分成甲、乙两组,每组各有59例患者,甲组应用度洛西汀治疗,乙组应用帕罗西汀治疗,对比两组患者的治疗效果。结果两组患者治疗后HAMD评分均有显著降低(P<0.05),但组间对比无明显差异(P>0.05);甲组痊愈率是61.0%,临床总有效率是84.7%;乙组痊愈率是40.7%,临床总有效率是83.1%,组间临床总有效率对比无显著性差异(P>0.05),而甲组痊愈率要显著高于乙组。结论度洛西汀与帕罗西汀治疗老年抑郁症均能获得较好治疗效果,但度洛西汀具有临床症状改善显著等优势,值得在临床上大力推广应用。 Objective To compare the geriatric depression Duloxetine and Paroxetine clinical curative effect of treatment. Methods Our hospital 118 cases of senile depression patients on the basis of treatment is divided into A, B two groups, each group has 59 patients, A groups was treated with Duloxetine, B groups was treated with Paroxetine, compared the therapeutic effect of two groups of patiems. Results Two groups of patients with HAMD scores were significantly lower after treatment (P〈0.05), but no difference between the comparison between groups (P〉0.05); a groups cure rate is 61.0%, the clinical total effective rate is 84.7%; B groups cure rate is 40.7%, the clinical total effective rate is 83.1%, contrast between clinical total effective rate was not significant difference (P〉0.05), and the cure rate of group A was significantly higher than that of group B. Conclusion Duloxetine and Paroxetine treatment of senile depression can get better treatment effect, but duloxetine has the advantages of the clinical symptoms improved significantly, is worth the clinical promoted application.
出处 《中国医药指南》 2017年第16期34-35,共2页 Guide of China Medicine
关键词 老年抑郁症 度洛西汀 帕罗西汀 Geriatric depression Duloxetine Paroxetine
  • 相关文献

参考文献4

二级参考文献35

  • 1栗克清,崔泽,崔利军,江琴普,武浩然,张武文,黄敬,靳建勋,王学义,徐建国,陶钧,张彦平,张本,张玉夫,侯海山,耿建萍,赵恩义,石光.河北省精神障碍的现况调查[J].中华精神科杂志,2007,40(1):36-40. 被引量:132
  • 2张璐璐,郑洪波.盐酸度洛西汀介绍[J].临床精神医学杂志,2007,17(4):284-285. 被引量:34
  • 3Nierenberg AA,Greis JH,Mallinckrodt CH,et al.Duloxetine versus escitalopram and placebo in the treatment of patients with major depress disorder; onset of antidepressant action,a non-inferiority study[J].Curr Med Res Opin,2007,23(2):401-416.
  • 4Hirschfeld RM,Mallinckrodt C,Lee TC,et al.Time course of depression symptom improvement during treatment with duloxetine[J].Depress Anxiety,2005,21(4):170-177.
  • 5Perahia DC,Wang F,Ed Wood,et al.Duloxetine in the treatment of major depressive disorder:a placebo and paroxetiue controlled trial[J].Eur Psychiatry,2006,21(6):367-378.
  • 6Bailey RK,Mallinckrodt CH,Wohlreich MM,et al.Duloxetine in the treatment of major depressive disorder:comparison of safety and efficacy[J].J Natl Med Assoc,2006,98(3):437-448.
  • 7Barkin RL,Barkin S.The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain,chronic pain,and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy[J].AM J Ther,2005,12:431-438.
  • 8westamno AD,Gayken J.Haight R Duloxetine:a balanced and selective norepinephrine-and serotonin-reuptake inhibitor[J].Am J Health Syst pharm,2005,62:2481-2490.
  • 9Wise TN,Arnold LM,Maletic V.Management of painful physical symptoms associated with depression and mood disorders[J].CNS spectr,2005,10:1-13.
  • 10World Health Organization. The World Health Report: 1994: New Understand, New Hope[ M]. Printed in France, 1994:93.

共引文献39

同被引文献17

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部